PROMYELO

ProMyelo GmbH is a highly specialized preclinical research organization offering services that focus on the development of new neural therapies, especially in the field of Multiple Sclerosis research. ProMyelo's various preclinical MS model Systems (cuprizone, EAE, LPC etc.) and applications (immunohistochemistry, ultrastructural analyses, gene expression studies, cell culture approaches, etc.) provide high-quality standard and customizable solutions for basic science, preclinical and clinical research. We provide these specialized research services to pharmaceutical & biotechnology companies, non-profit organizations and academic researchers... We offer services focusing on the development of new remyelination therapies in Multiple Sclerosis. We use the cuprizone model, EAE and focal remyelination, and provide high-quality Research and Development (RD).

Also known as: ProMyelo GmbH

VAT numbers: DE812610170

Primary location: Rostock Germany